Synlico Inc.


Synlico Inc. is a pioneering biotechnology company focused on revolutionizing medicine through AI-driven drug discovery and causal cell modeling. Their mission is to develop potent therapies for various diseases by integrating artificial intelligence, single-cell bioinformatics, and causal modeling to make cellular processes explainable, predictable, and engineerable.

Industries

biotechnology
life-science
medical
therapeutics

Nr. of Employees

small (1-50)

Synlico Inc.

South San Francisco, California, United States, North America


Products

Causal AI platform for predicting cell behavior

A computational platform that integrates causal discovery, machine learning, and single-cell bioinformatics to predict how genetic or cellular interventions alter cell behavior in patient microenvironments, and to inform targeted therapeutic design.


Services

Collaborative AI-based drug discovery research

Partnerships and collaborative research using causal inference and single-cell analysis to support design and prediction of therapeutic interventions.

Industry presentation and validation engagements

Participation in industry challenges and presentations to pharmaceutical R&D and data science leadership for external validation and partner discovery.

Bioinformatics pipeline development services

Design and implementation of scalable pipelines for processing single-cell and other genomic datasets to support downstream modeling and analysis.

Expertise Areas

  • AI-driven drug discovery
  • Single-cell bioinformatics
  • Causal inference in biology
  • Machine learning for biological data
  • Show More (3)

Key Technologies

  • Causal discovery algorithms
  • Deep learning / machine learning
  • Single-cell RNA sequencing analysis
  • Scalable bioinformatics pipelines
  • Show More (3)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.